ESG Report 2024

5 About The United Laboratories 3.2 The Group is a comprehensive and modernised pharmaceutical enterprise engaged in the research and development, production and operation, and the products covering pharmaceutical intermediate products, bulk medicines, finished products, veterinary drugs, empty capsules and medical devices. The Group currently has seven major production sites including The United Laboratories Co., Ltd. (“Hong Kong Company”), Zhuhai United Laboratories Co., Ltd. (“Zhuhai Company”), Zhuhai United Laboratories Co. Ltd. Zhongshan Branch (“Zhongshan Company”), Guangdong Kaiping Kingly Capsule Co., Ltd., United Laboratories (Inner Mongolia Company) Co., Ltd. (“Inner Mongolia Company”), The United Animal Healthcare (Inner Mongolia) Co., Ltd. (“The United Animal Healthcare”), and Kendor Technology (Zhejiang) Co., Ltd. (“Kendor Company”). The total number of employees were approximately 17,000 at the end of the year. 3.2.1 The Group Introduction Since its establishment, the Group has been dedicated to the production of high-quality pharmaceuticals. All our factories have attained the certification of Chinese Good Manufacturing Practice (“cGMP”), and multiple products have obtained official certifications such as the Certification of Suitability to the Monographs of the European Pharmacopoeia Organisation and the US Food and Drug Administration (“FDA”). We adhere to self-innovations and possess strong research and development capabilities. Our products cover multiple fields including anti-infective drugs, diabetes drugs, nervous system drugs, ophthalmology drugs, topical dermatology drugs and others. Multiple scientific and technological achievements of the Group have obtained national patents. Talents are the most important assets of an enterprise. The Group priorities building a high-caliber talent team, continuously improves human resource management, establishes and improves our talent training, selection and education mechanism, and has gradually formed a “Friendly, Responsible, Hardworking and Efficient” workforce. We always adhere to the philosophy of “To Make Life More Valuable” to promote the development of environmental protection and the charity sector with a high sense of social responsibility. As for environmental protection, we have made huge investment in creating a green enterprise. We actively support charities in multiple fields such as education, poverty alleviation and social welfare. Our efforts have been recognised by social community, which reflected our responsibilities and missions as a modern enterprise. In the future, the Group will continue to dedicate its efforts to the creation of an outstanding Chinese pharmaceutical brand, promote the development of the national medical and healthcare industry, and create more high-quality and highly effective pharmaceuticals. 3.2.2 Philosophy and Vision Love China, For China Corporate Mission To Make Life More Valuable Corporate Tenet Kind, Conscientious, Diligent and Highly-efficient Core Culture Corporate Objective (Vision) To Manufacture First-class Products, Provide First-class Service, Cultivate First-class Professionals, be a Model in the Pharmaceutical Industry Devoted to Producing Safe and Effective Medicines Core Value We Cherish not only Economic Benefits, but also Green Mountains and Lucid Water, Blue Sky and White Clouds Environmental Protection Concept Friendship, Equality, and Joint Development Business Principle Pragmatic and Rigorous, Scientific Truth-seeking, Future-oriented, and Innovative R&D Philosophy Environmental, Social and Governance Report 2024 The United Laboratories International Holdings Limited